Back to Journals » Clinical Interventions in Aging » Volume 2 » Issue 4
Peripheral arterial disease in the elderly
Authors Aronow W
Published 15 January 2008 Volume 2007:2(4) Pages 645—654
Wilbert S Aronow
Cardiology Division, Department of Medicine, New York Medical College, Valhalla, New York
Abstract: Smoking should be stopped and hypertension, diabetes mellitus, dyslipidemia, and hypothyroidism treated in elderly patients with peripheral arterial disease (PAD) of the lower extremities. Statins reduce the incidence of intermittent claudication and improve exercise duration until the onset of intermittent claudication in patients with PAD and hypercholesterolemia. Antiplatelet drugs such as aspirin or clopidogrel, especially clopidogrel, angiotensin-converting enzyme inhibitors, and statins should be given to all elderly patients with PAD without contraindications to these drugs. Beta blockers should be given if coronary artery disease is present. Exercise rehabilitation programs and cilostazol increase exercise time until intermittent claudication develops. Chelation therapy should be avoided. Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in patients interfering with work or lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested by rest pain, non-healing ulcers, and/or infection or gangrene; and (3) vasculogenic impotence.
Keywords: peripheral arterial disease, intermittent claudication, antiplatelet drugs, statins, angiotensin-converting enzyme inhibitors, cilostazol, exercise rehabilitation, revascularization
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.